Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

6Total

Not Applicable (2)

P 2 (1)

P 3 (3)

Trial Status

Completed4

Recruiting3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT05199857Not ApplicableCompleted

WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program

NCT07686341Recruiting

PRecision Integrated Saturation Monitor

NCT06762964Phase 2Recruiting

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

NCT05918211Phase 3RecruitingPrimary

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

NCT03430583Phase 3CompletedPrimary

Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness

NCT02741115Phase 3CompletedPrimary

Fontan Udenafil Exercise Longitudinal Assessment Trial

NCT03687008Not ApplicableCompletedPrimary

Cognitive Intervention to Improve Working Memory

Showing all 7 trials

Single Ventricle Heart Disease